Navigation Links
New Antibiotic Helps Prevent Recurrence of Dangerous Gut Infection
Date:2/2/2011

By Maureen Salamon
HealthDay Reporter

WEDNESDAY, Feb. 2 (HealthDay News) -- Late-stage clinical trials of a new antibiotic for the increasingly common intestinal infection Clostridium difficile, which is especially lethal to the elderly, suggest it prevents recurrence far better than currently used medications.

Researchers tested the new drug, fidaxomicin, against vancomycin, a powerful drug often prescribed to C. difficile patients. These cases often involve virulent diarrhea and colon inflammation that proves fatal to an estimated 5,000 Americans each year, according to federal statistics.

People over age 65, especially those in hospitals and nursing homes, are more vulnerable to the infection, which experts estimate strikes up to 3 million Americans annually, many of whom have taken broad-spectrum antibiotics to treat other illnesses.

Among the 629 patients studied, fidaxomicin was associated with a 45 percent lower rate of recurrence than vancomycin, which researchers said was due to fidaxomicin's ability to precisely target C. difficile bacteria in the gut. Vancomycin has a similar clinical cure rate, but it kills more "good" intestinal bacteria bugs that help keep C. difficile at bay, explained study co-author Dr. Sherwood Gorbach.

"It's virtually impossible to beat vancomycin as a cure, but [using fidaxomicin] we could beat it with recurrence," said Gorbach, professor of medicine, immunology, molecular biology and microbiology at Tufts University School of Medicine in Boston.

"Fidaxomicin does kill the bug, but in terms of recurrence, it doesn't disturb the normal balance of flora in the intestines," he said. "This drug should actually save lives."

The study was funded by Optimer Pharmaceuticals, which is developing fidaxomicin, and is published in the Feb. 3 issue of the New England Journal of Medicine.

While vancomycin is often used as a last
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Giant Eagle Pharmacy Free Antibiotics Program Surpasses $3 Million in Free Prescriptions
2. Poll: Hypothetical anthrax attack and antibiotics
3. Chitosan as alternative to growth-promoting antibiotics for ruminants
4. Penicillin Allergy Might Not Include Related Antibiotic
5. Hard to Treat Diseases (HTDS) Awarded Two Antibiotics Certificates For Chile
6. ID physicians call for 10 new antibiotics by 2020
7. Misinformation About Antibiotics Can Travel to Large Audience Via Twitter: Study
8. Misinformation about antibiotics can travel to large audience via Twitter: study
9. Researchers find compound effective in destroying antibiotic-resistant biofilms
10. Antibiotic regimen effective for reactive arthritis
11. Combination antibiotics effective against chlamydia-induced arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Antibiotic Helps Prevent Recurrence of Dangerous Gut Infection
(Date:7/22/2014)... Today, Therapy Changes announces the start of their Teen ... help increase their knowledge and ability to cope with life’s ... to make healthy and positive decisions while connecting with like-minded ... but also a time of major life transition and stress,” ... . , “Teens can at times feel misunderstood, so rather ...
(Date:7/22/2014)... Quebec (PRWEB) July 22, 2014 ... is a set of simple tools, designed to help ... have little or no experience with biofeedback. The tools ... stressful situations and elucidate any abnormal patterns to teach ... today’s fast paced world, we are familiar with stress ...
(Date:7/22/2014)... Mass. (PRWEB) July 22, 2014 ... EBSCO Information Services , announces the launch ... assist occupational health and safety professionals employed by ... chemicals and need to manage the impact of ... PoisonEXPERT provides access to relevant chemical-specific information and ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 The Muscular Dystrophy ... the third annual MUSCLE UP campaign that will ... more than one million Americans fighting muscle disease. ... to visit participating Jiffy Lube service centers through Sept. 1, ... to continue to make progress in the fight for muscle ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 Brand ... landed MediaSource as a Ragan Communications 2014 Health ... will be the second consecutive year that MediaSource placed ... which was awarded to the winning MediaSource team last ... to keep this title against three other contenders that ...
Breaking Medicine News(10 mins):Health News:Therapy Changes Announces Teen Support Group Therapy 2Health News:Thought Technology to Present Software for Stress Control at the 2014 American Psychological Association Convention in DC 2Health News:Thought Technology to Present Software for Stress Control at the 2014 American Psychological Association Convention in DC 3Health News:PoisonEXPERT™ from ExPub Now Available 2Health News:PoisonEXPERT™ from ExPub Now Available 3Health News:Jiffy Lube® Supports Fight Against Muscle Disease with Third Annual MUSCLE UP® Campaign 2Health News:Jiffy Lube® Supports Fight Against Muscle Disease with Third Annual MUSCLE UP® Campaign 3Health News:MediaSource Brand Journalism Returns to Best Health Care Agency Competition in Ragan Communications Health Care Awards 2Health News:MediaSource Brand Journalism Returns to Best Health Care Agency Competition in Ragan Communications Health Care Awards 3
... to Serve Elective Cash Pay ... ... financial services for elective (cash pay) surgery, today,announced a leap forward in ... for bariatric surgeons, cash pay business.,Beginning July 1st, 2008, the BLISCare(SM) insurance ...
... chemotherapeutic agents remains a large problem. In some cases, ... cellular process known as translation, which is central to ... Pelletier and colleagues, at McGill University, Montreal, have identified ... cancer cells to standard anticancer chemotherapeutic agents. , In ...
... a healthier life, study finds , , THURSDAY, June 12 ... aging, a new study found. , Researchers at the ... 60 and older for use of sleeping aids, daytime ... quality, and sleep duration. Based on the results, 20.8 ...
... FDA on food safety , , THURSDAY, June 12 (HealthDay ... ongoing outbreak of salmonella-contaminated tomatoes has risen to 228 ... reported Thursday. , Also Thursday, Congressional investigators said the ... its own stated goals of protecting the nation,s food ...
... Pa., June 12 MEDRAD, INC., has ... PETNET Solutions,a fully owned subsidiary of Siemens ... health care providers to inject Fluorodeoxyglucose,(FDG) for ... an innovative, new way. The partnership will ...
... of Excellence (CCE), the,nation,s only practice-owned and physician ... slate and Board of Directors.,Effective immediately, J. Ike ... the interim President of CCE. In addition, Linda,Bosserman, ... Medical,Officer. Dr. Bosserman had previously served as CCE,s ...
Cached Medicine News:Health News:BLIS to Offer Coverage Through 'A' Rated Insurance Carrier 2Health News:BLIS to Offer Coverage Through 'A' Rated Insurance Carrier 3Health News:Better Sleepers Are 'Successful Agers' 2Health News:228 People in 22 States Sickened in Ongoing Salmonella-Tomato Outbreak 2Health News:228 People in 22 States Sickened in Ongoing Salmonella-Tomato Outbreak 3Health News:228 People in 22 States Sickened in Ongoing Salmonella-Tomato Outbreak 4Health News:228 People in 22 States Sickened in Ongoing Salmonella-Tomato Outbreak 5Health News:MEDRAD and PETNET Solutions Partner for Innovative FDG Delivery 2Health News:MEDRAD and PETNET Solutions Partner for Innovative FDG Delivery 3Health News:Cancer Clinics of Excellence (CCE) Announces Management and Board of Directors Slate at 1st Annual General Membership Meeting 2
(Date:7/22/2014)... 2014  ConvaTec, a privately-held medical products and technologies ... been appointed chief financial officer of the company, effective ... executive vice president and chief financial officer of Elan ... Mr. Clerkin was part of a senior team that ... its sale to Perrigo, a pharmaceutical manufacturer, in December ...
(Date:7/22/2014)... , July 22, 2014  According to the American ... children spend on digital devices. An AOA survey reports ... 10 and 17 estimate they use an electronic device ... separate AOA survey of parents revealed that only 40 ... device for that same amount of time. Eye doctors ...
(Date:7/22/2014)... , July 22, 2014  NeuroSigma, Inc. (NeuroSigma), ... focused on commercialization of its non-invasive Monarch ... and neuropsychiatric disorders, today announced that enrollment has begun ... nerve stimulation (eTNS) as adjunctive therapy for the treatment ... being conducted at the Olive View-UCLA Medical Center in ...
Breaking Medicine Technology:ConvaTec Names Nigel Clerkin Chief Financial Officer 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 3Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 4Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 2Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 3Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 4Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 5
... Infection Prevention Professionals With Guidelines,and Tools, ... Association for,Professionals in Infection Control and ... new educational initiatives aimed at eliminating,healthcare-associated ... and the three infections that the ...
... Innocoll, Inc., a privately-held,specialty pharmaceutical company, announced ... clinical trials sponsored by its wholly owned ... TOPICAL for the,treatment and prevention of infected ... GENTAMICIN TOPICAL is a biodegradable and fully ...
Cached Medicine Technology:APIC Launches 'Targeting Zero' Initiative to Eradicate C. Difficile and Infections Deemed Preventable By CMS 2APIC Launches 'Targeting Zero' Initiative to Eradicate C. Difficile and Infections Deemed Preventable By CMS 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: